Camilla Sylvest
Directeur/Membre du Conseil chez ARGENX SE
Fortune : 84 396 $ au 30/04/2024
Profil
Ms. Camilla Sylvest is an Independent Non-Executive Director at argenx SE, an EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A/S, an Independent Director at Danish Crown A/S and a Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
She is on the Board of Directors at argenx SE, Danish Crown A/S and World Diabetes Foundation.
She received her graduate degree from the University of Southern Denmark and an MBA from Scandinavian International Management Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARGEN-X SE
0,00% | 20/02/2024 | 225 ( 0,00% ) | 84 396 $ | 30/04/2024 |
Postes actifs de Camilla Sylvest
| Sociétés | Poste | Début |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2003 |
| ARGENX SE | Directeur/Membre du Conseil | 08/09/2022 |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18/10/2011 |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Directeur/Membre du Conseil | - |
| World Diabetes Foundation | Directeur/Membre du Conseil | - |
Formation de Camilla Sylvest
| Scandinavian International Management Institute | Masters Business Admin |
| University of Southern Denmark | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ARGENX SE | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
| World Diabetes Foundation | Miscellaneous |
